PharmiNews

Directory of Pharma Companies and News

Company Profile

BioThrax

BioThrax logo
Category
BioThrax is the only anthrax vaccine licensed by the U.S. Food and Drug Administration, the Singapore Health Sciences Authority, and Germany’s Paul-Ehrlich-Institut, for the prevention of anthrax disease. The safety and efficacy of BioThrax have not been established in pediatric or geriatric populations. Individuals are not considered protected until they have completed the three-dose primary immunisation series. Vaccination with BioThrax may not protect all individuals. BioThrax is manufactured from a culture filtrate, made from a non-virulent strain of Bacillus anthracis. Over 14 million doses of BioThrax have been administered to more than 3 million individuals.
Keywords:
0 results
Brought to you by PharmiWeb.com - Latest Jobs in Pharma